Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 6Thoracic 1Sarcoma 1

Conditions

Sarcoma 4Sarcoma, Ewing 3Osteosarcoma 3Liposarcoma 3Rhabdomyosarcoma 2Rhabdoid Tumor 2Neuroblastoma 2Diffuse Intrinsic Pontine Glioma 2Breast Neoplasms 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Retinoblastoma 1Recurrence 1Pathologic Complete Response 1Neoplasms 1Neoplasm Metastasis 1Medulloblastoma 1Leiomyosarcoma 1Hemangiosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Colonic Neoplasms 1Chondrosarcoma 1Cholangiocarcinoma 1Acquired Immunodeficiency Syndrome 1

Interventions

Temozolomide 51Bevacizumab 23Radiotherapy 16Magnetic Resonance Spectroscopy 16Irinotecan 15Carmustine 12Erlotinib Hydrochloride 10Carboplatin 8Surgical Procedures, Operative 6O(6)-benzylguanine 6Imatinib Mesylate 6Filgrastim 6Cyclophosphamide 6Biopsy 6sargramostim 5aldesleukin 5X-Rays 5Thalidomide 5Phantoms, Imaging 5Chemotherapy, Adjuvant 52-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 5temsirolimus 4Topotecan 4Specimen Handling 4Sirolimus 4Radiation 4Peripheral Blood Stem Cell Transplantation 4Nuclear Medicine Department, Hospital 4Etoposide 4Cisplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × abemaciclib × Sarcoma × Clear all
NCT04238819 2026-03-02

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Eli Lilly and Company

Phase 1/2 Completed
47 enrolled 36 charts
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡